rts logo

New Big Money Means ReShape Lifesciences Inc. (RSLS) Investors Could Reap Benefit

ReShape Lifesciences Inc. (NASDAQ: RSLS) is -17.10% lower on its value in year-to-date trading and has touched a low of $0.14 and a high of $1.66 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RSLS stock was last observed hovering at around $0.22 in the last trading session, with the day’s loss setting it -0.01%.

Currently trading at $0.21, the stock is 2.79% and 4.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.03 million and changing -4.92% at the moment leaves the stock -8.49% off its SMA200. RSLS registered -85.92% loss for a year compared to 6-month loss of -10.20%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -8.00% gain in the last 1 month and extending the period to 3 months gives it a 19.21%, and is 7.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.06% over the week and 13.48% over the month.

ReShape Lifesciences Inc. (RSLS) has around 31 employees, a market worth around $4.86M and $8.34M in sales. Profit margin for the company is -130.99%. Distance from 52-week low is 46.39% and -87.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-234.24%).

The shares outstanding are 23.46M, and float is at 20.81M with Short Float at 1.09%.

ReShape Lifesciences Inc. (RSLS) Insider Activity

The most recent transaction is an insider sale by STANKOVICH THOMAS, the company’s Chief Financial Officer. SEC filings show that STANKOVICH THOMAS sold 131 shares of the company’s common stock on Oct 25 ’23 at a price of $0.27 per share for a total of $35.0. Following the sale, the insider now owns 22949.0 shares.

ReShape Lifesciences Inc. disclosed in a document filed with the SEC on Oct 11 ’23 that STANKOVICH THOMAS (Chief Financial Officer) sold a total of 39 shares of the company’s common stock. The trade occurred on Oct 11 ’23 and was made at $0.93 per share for $36.0. Following the transaction, the insider now directly holds 23080.0 shares of the RSLS stock.

Still, SEC filings show that on Sep 01 ’23, STANKOVICH THOMAS (Chief Financial Officer) disposed off 118 shares at an average price of $0.89 for $105.0. The insider now directly holds 23,119 shares of ReShape Lifesciences Inc. (RSLS).

Related Posts